Streetbeat News

Revenues

HR

Healthcare Realty Trust (NYSE:HR) has received mixed analyst ratings over the past three months, with a shift towards more bearish sentiments recently. Analysts have adjusted their price targets upwards, with an average target of $17.2, reflecting a 6.17% increase from previous estimates. Despite these adjustments, the company faces financial challenges, including a decline in revenue and below-industry-average profitability metrics.

Portfolio Pulse from Benzinga Insights

October 01, 2024 | 7:00 pm

CLX

Jefferies analyst Kaumil Gajrawala upgraded Clorox Company (NYSE:CLX) to Buy, raising the price target to $187. The analyst predicts Clorox will achieve earnings beats and a 3-year growth surge, driven by improved topline growth and operating leverage. Clorox aims for a 3-5% organic sales CAGR through fiscal 2028.

Portfolio Pulse from Nabaparna Bhattacharya

October 01, 2024 | 6:48 pm

CELH

Celsius Holdings (NASDAQ:CELH) has significantly outperformed the market over the past 5 years, with an annualized return of 82.1% and an average annual return of 96.34%. A $1000 investment in CELH 5 years ago would now be worth $28,735.98.

Portfolio Pulse from Benzinga Insights

October 01, 2024 | 6:32 pm

CBOE

Cboe Global Markets (BATS:CBOE) has outperformed the market over the past decade with an average annual return of 14.58%, resulting in a $1000 investment growing to $3,861.26. The article highlights the power of compounded returns.

Portfolio Pulse from Benzinga Insights

October 01, 2024 | 6:32 pm

AIG

ALL

DUK

NXRT

PEB

SUI

Hurricane Helene caused significant devastation in the southeastern US, affecting power and insurance sectors. Duke Energy faced major outages, while insurers like AIG and Allstate are assessing potential losses. REITs reported minimal damage.

Portfolio Pulse from Hayden Buckfire

October 01, 2024 | 6:21 pm

SQ

Block (NYSE:SQ) has been analyzed by 11 analysts, showing a range of opinions from bullish to bearish. The average 12-month price target is $84.91, down 6.79% from the previous $91.10. Analysts have adjusted their ratings and price targets, reflecting market conditions and company performance. Block's financials show positive revenue growth but challenges in profitability and asset utilization.

Portfolio Pulse from Benzinga Insights

October 01, 2024 | 6:02 pm

TWST

Twist Bioscience (NASDAQ:TWST) has received mixed analyst ratings over the past three months, with a recent positive shift in average price targets. Analysts have set a 12-month average price target of $49.4, up 9.78% from the previous $45.00. The company's financials show a positive revenue trend but face challenges with net margin, ROE, and ROA.

Portfolio Pulse from Benzinga Insights

October 01, 2024 | 6:01 pm

SBRA

Analysts have varied ratings for Sabra Health Care REIT (NASDAQ:SBRA), with recent upgrades in price targets. The average 12-month target is now $18.75, up from $16.00, indicating positive sentiment. Sabra's financials show strong revenue growth and profitability, with a conservative debt approach.

Portfolio Pulse from Benzinga Insights

October 01, 2024 | 6:01 pm

SATS

EchoStar (NASDAQ:SATS) has been evaluated by four analysts over the past three months, with opinions ranging from bullish to bearish. The average 12-month price target has increased to $21.0, up 7.69% from the previous $19.50. Analysts have adjusted their ratings and price targets, reflecting their response to EchoStar's market position and financial health. The company faces challenges with declining revenue, low net margins, and below-average ROE and ROA, but maintains a balanced debt management strategy.

Portfolio Pulse from Benzinga Insights

October 01, 2024 | 6:00 pm

PLD

Prologis (NYSE:PLD) has outperformed the market over the past decade with an average annual return of 12.75%, resulting in a $1000 investment growing to $3,282.53. This highlights the power of compounded returns over time.

Portfolio Pulse from Benzinga Insights

October 01, 2024 | 6:00 pm